M. V. Pereviazkina, “Efficiency assessment for antihypertensive, hemodynamic, renal effects of adenosine-converting enzyme (ACE) inhibitors and irbesartan and impact on endothelial disfunction in patients with stage II hypertension”, Zaporozhye Medical Journal, vol. 16, no. 4, Sep. 2014.